ArticleTranslational oncology2026
Prediction of immune-related adverse events in urological cancer during checkpoint inhibitor immunotherapy through immunohistochemical analysis of tumorous LCP1/ADPGK.
Liqing Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.